This study assessed the prophylactic bethanechol use to prevent salivary gland dysfunction during radiotherapy. A total of 97 head and neck cancer patients were allocated into two groups: Bethanechol or Placebo. Bethanechol group presented significantly improve of salivary parameters. Bethanechol was effective in decreasing the salivary gland damage.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2015.03.017DOI Listing

Publication Analysis

Top Keywords

salivary gland
12
gland dysfunction
8
head neck
8
neck cancer
8
cancer patients
8
bethanechol
5
double blind
4
blind randomized
4
randomized prospective
4
prospective trial
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!